Methods for assessment of tissue sites of lipoprotein degradation.
D000818:Animals; D016632:Apolipoprotein A-I; D001054:Apolipoproteins A / Q000378:metabolism; D002250:Carbon Radioisotopes; D003432:Cross-Linking Reagents; D007202:Indicators and Reagents; D008074:Lipoproteins / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008954:Models, Biological; D009928:Organ Specificity; D011865:Radioisotope Dilution Technique; D011887:Raffinose / Q000378:metabolism; D013395:Sucrose / Q000378:metabolism; D014227:Triazines; D014316:Tritium
D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D002250:Carbon Radioisotopes; D003432:Cross-Linking Reagents; D007202:Indicators and Reagents; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014227:Triazines; D014316:Tritium; D013395:Sucrose; C019309:cyanuric chloride; D011887:Raffinose